美国 · SEC FORM 4
Royalty Pharma plc
RPRX · Nasdaq · CIK 0001802768 · Healthcare · Biotechnology
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
40 同一窗口内观察到的 Form 4 交易行
21 sales · 19 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2023-06-28 · Legorreta Pablo G. · $3.8M
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出High
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Urist MarshallEVP, Research & Investments
○▼▼▼▼○▼▼
Hite ChristopherEVP & Chairman, Partnering
○▼▼○▼○▼
Coyne Terrance P.EVP & CFO
▼○▼○▼
Bassler Bonnie LDirector
○○○
Norden GregoryDirector
▼○
Legorreta Pablo G.CEO, Chairman of the Board
○○
● 买入▼ 卖出○ 其他
Showing the six most active owners; 6 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2023-06-28 · Legorreta Pablo G..
近期 Form 4 活动
0买入
74卖出
31其他 Form 4 交易行
67SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出21 sale line(s) · 仅供背景
其他19 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 12,885,147
- 上期报告
- 11,647,565
- 日均成交量
- 2,901,553
- 回补天数
- 4.4
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2023-06-28 | Legorreta Pablo G. | 买入 (P) | Class A ordinary shares | 130,000 | USD 29.51 | USD 3,836,300 | SEC 申报 ↗ |
| 2023-06-13 | Legorreta Pablo G. | 买入 (P) | Class A ordinary shares | 45,000 | USD 32.78 | USD 1,475,100 | SEC 申报 ↗ |
| 2023-06-12 | Legorreta Pablo G. | 买入 (P) | Class A ordinary shares | 45,000 | USD 33.00 | USD 1,485,000 | SEC 申报 ↗ |
| 2023-05-24 | Legorreta Pablo G. | 买入 (P) | Class A ordinary shares | 150,000 | USD 32.25 | USD 4,837,500 | SEC 申报 ↗ |
| 2023-05-17 | Legorreta Pablo G. | 买入 (P) | Class A ordinary shares | 69,612 | USD 32.94 | USD 2,293,019 | SEC 申报 ↗ |
| 2023-05-16 | Legorreta Pablo G. | 买入 (P) | Class A ordinary shares | 160,388 | USD 33.57 | USD 5,384,225 | SEC 申报 ↗ |
| 2022-02-24 | Fernandez Henry A | 买入 (P) | Class A Ordinary Shares | 32,500 | USD 37.49 | USD 1,218,425 | SEC 申报 ↗ |
| 2021-02-25 | Fernandez Henry A | 买入 (P) | Class A Ordinary Shares | 25,700 | USD 46.83 | USD 1,203,531 | SEC 申报 ↗ |
| 2020-06-18 | RIGGS RORY B | 买入 (P) | Class A Ordinary Shares | 15,000 | USD 28.00 | USD 420,000 | SEC 申报 ↗ |
| 2020-06-18 | Hite Christopher | 买入 (P) | Class A Ordinary Shares | 70,000 | USD 28.00 | USD 1,960,000 | SEC 申报 ↗ |
| 2020-06-18 | Coyne Terrance P. | 买入 (P) | Class A Ordinary Shares | 2,950 | USD 28.00 | USD 82,600 | SEC 申报 ↗ |
| 2020-06-18 | Lloyd George W. | 买入 (P) | Class A Ordinary Shares | 14,200 | USD 28.00 | USD 397,600 | SEC 申报 ↗ |
| 2020-06-18 | Legorreta Pablo G. | 买入 (P) | Class A Ordinary Shares | 10,000 | USD 28.00 | USD 280,000 | SEC 申报 ↗ |
| 2020-06-18 | FORD WILLIAM E | 买入 (P) | Class A Ordinary Shares | 1,500,000 | USD 28.00 | USD 42,000,000 | SEC 申报 ↗ |
| 2020-06-18 | Avara Management Ltd; Giuliani Mario Germano; Nogra Group SICAF SIF GG Strategic; Nogra Group SICAF SIF MGG Strategic; Skyeline Management Ltd | 买入 (P) | Class A Ordinary Shares | 50,000 | USD 28.00 | USD 1,400,000 | SEC 申报 ↗ |
Form 4 申报证据
105 transaction lines in the latest 365-day window; 486 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Urist Marshall | 卖出 (S) | Class A Ordinary Shares | 4,126 | USD 57.10 | USD 235,595 | SEC 申报 ↗ |
| 2026-09-30 | Bassler Bonnie L | 奖励／授予 (A) | Class A Ordinary Shares | 642 | USD 58.41 | USD 37,499 | SEC 申报 ↗ |
| 2026-09-28 | Urist Marshall | 卖出 (S) | Class A Ordinary Shares | 4,126 | USD 57.88 | USD 238,813 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Urist Marshall | 卖出 (S) | Class A Ordinary Shares | 4,126 | USD 57.10 | USD 235,595 | SEC 申报 ↗ |
| 2026-09-30 | Bassler Bonnie L | 奖励／授予 (A) | Class A Ordinary Shares | 642 | USD 58.41 | USD 37,499 | SEC 申报 ↗ |
| 2026-09-28 | Urist Marshall | 卖出 (S) | Class A Ordinary Shares | 4,126 | USD 57.88 | USD 238,813 | SEC 申报 ↗ |
| 2026-09-22 | Hite Christopher | 卖出 (S) | Class A Ordinary Shares | 100,000 | USD 58.53 | USD 5,852,649 | SEC 申报 ↗ |
| 2026-08-19 | Hite Christopher | 赠与 (G) | Class A Ordinary Shares | 16,800 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-18 | Hite Christopher | 卖出 (S) | Class A Ordinary Shares | 100,000 | USD 59.97 | USD 5,997,000 | SEC 申报 ↗ |
| 2026-08-13 | Coyne Terrance P. | 卖出 (S) | Class A Ordinary Shares | 11,002 | USD 58.68 | USD 645,582 | SEC 申报 ↗ |
| 2026-08-05 | Urist Marshall | 奖励／授予 (A) | Class A Ordinary Shares | 8,252 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-05 | Legorreta Pablo G. | 奖励／授予 (A) | Class A Ordinary Shares | 65,216 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-05 | Hite Christopher | 奖励／授予 (A) | Class A Ordinary Shares | 11,002 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-05 | Coyne Terrance P. | 奖励／授予 (A) | Class A Ordinary Shares | 11,002 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-01 | Urist Marshall | 卖出 (S) | Class A Ordinary Shares | 9,099 | USD 55.88 | USD 508,452 | SEC 申报 ↗ |
| 2026-06-30 | Hite Christopher | 卖出 (S) | Class A Ordinary Shares | 130,000 | USD 56.50 | USD 7,345,122 | SEC 申报 ↗ |
| 2026-06-30 | Bassler Bonnie L | 奖励／授予 (A) | Class A Ordinary Shares | 689 | USD 54.40 | USD 37,482 | SEC 申报 ↗ |
| 2026-06-24 | Urist Marshall | 卖出 (S) | Class A Ordinary Shares | 9,098 | USD 55.18 | USD 502,028 | SEC 申报 ↗ |
| 2026-06-23 | Hite Christopher | 卖出 (S) | Class A Ordinary Shares | 150,000 | USD 54.39 | USD 8,158,833 | SEC 申报 ↗ |
| 2026-06-05 | WEATHERMAN ELIZABETH H | 奖励／授予 (A) | Class A Ordinary Shares | 4,545 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | Norden Gregory | 奖励／授予 (A) | Class A Ordinary Shares | 4,545 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | LOVE TED W | 奖励／授予 (A) | Class A Ordinary Shares | 4,545 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | Ho Carole | 奖励／授予 (A) | Class A Ordinary Shares | 4,545 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | HODGSON DAVID C | 奖励／授予 (A) | Class A Ordinary Shares | 4,545 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | Engelbert Catherine M. | 奖励／授予 (A) | Class A Ordinary Shares | 4,545 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | Coric Vlad | 奖励／授予 (A) | Class A Ordinary Shares | 4,545 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | Bassler Bonnie L | 奖励／授予 (A) | Class A Ordinary Shares | 4,545 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-26 | Coyne Terrance P. | 卖出 (S) | Class A Ordinary Shares | 64,399 | USD 53.98 | USD 3,476,258 | SEC 申报 ↗ |
| 2026-05-20 | Urist Marshall | 卖出 (S) | Class A Ordinary Shares | 13,684 | USD 52.75 | USD 721,831 | SEC 申报 ↗ |
| 2026-05-14 | Urist Marshall | 卖出 (S) | Class A Ordinary Shares | 13,684 | USD 53.06 | USD 726,073 | SEC 申报 ↗ |
| 2026-05-14 | Norden Gregory | 卖出 (S) | Class A Ordinary Shares | 3,045 | USD 53.00 | USD 161,385 | SEC 申报 ↗ |
| 2026-05-06 | Urist Marshall | 奖励／授予 (A) | Class A Ordinary Shares | 18,197 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-06 | Legorreta Pablo G. | 奖励／授予 (A) | Class A Ordinary Shares | 143,821 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | RPRX |
| CIK | 0001802768 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 486 transaction lines from 2020-06-15 to 2026-10-05 18 P purchase lines · 260 S sale lines · 208 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.